Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy.
Riveros C, Ranganathan S, Xu J, Chang C, Kaushik D, Morgan M, Miles BJ, Muhammad T, Anis M, Aghazadeh M, Zhang J, Efstathiou E, Klaassen Z, Brooks MA, Rini B, Wallis CJD, Satkunasivam R.
Riveros C, et al. Among authors: morgan m.
Urol Oncol. 2023 Mar;41(3):150.e1-150.e9. doi: 10.1016/j.urolonc.2022.11.022. Epub 2023 Jan 5.
Urol Oncol. 2023.
PMID: 36610815